3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
5
Phase 4
2
Phase NA
1
Phase EARLY_PHASE1
1
Phase 2/3
1
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Thoracic Neoplasms
1
Platinum Resistant Ovarian Cancer
1
Neoplasms
1
Multiple Endocrine Neoplasia Type 1
1
Interventions
Trimethoprim, Sulfamethoxazole Drug Combination
4
gamma-Globulins
3
Standard of Care
3
Oxaliplatin
3
Melatonin
3
Gemcitabine
3
Fluorouracil
3
Drug Therapy
3
Ciprofloxacin
3
Capecitabine
3
pertuzumab
2
entrectinib
2
cobimetinib
2
capmatinib
2
atezolizumab
2
alectinib
2
Water
2
Vemurafenib
2
Trastuzumab
2
Sirolimus
2
Saline Solution
2
Pemetrexed
2
Methylphenidate
2
Lidocaine
2
Leucovorin
2
Immunoglobulins, Intravenous
2
Docetaxel
2
Dexmedetomidine
2
Cisplatin
2
Carboplatin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Neoplasms
×
Sodium Chloride
×
Clear all
NCT04741880
2021-07-30
ELSA
Instituto Nacional de Cancer, Brazil
Phase 2/3
Unknown
66 enrolled